1 active not recruiting, 1 completed. 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow ARTBIO Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) AB001 - Prostate Cancer (CRPC), Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Phase 1 | Active not recruiting | ARTBIO Inc. | 80 | 2025-11-03 | 2026-04-07 |
| Phase 0/1 Study of 212Pb-NG001 in mCRPC 212Pb-NG001 - Metastatic Castration-resistant Prostate Cancer | Early Phase 1 | Completed | ARTBIO Inc. | 3 | 2023-03-06 | 2023-10-06 |
Neoplasm Metastasis (1) · Prostatic Neoplasms (1)
Norway (1) · United States (1)